Cools A R, Prinssen E, Ellenbroek B A
Psychoneuropharmacological Research-Unit, University of Nijmegen, The Netherlands.
Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:618A-619A. doi: 10.1097/00002826-199201001-00320.
This study shows that the 5-HT2 antagonists ketanserin and ritanserin which on top of administration of classical neuroleptics reduces negative symptoms in schizophrenia as well as extrapyramidal side effects, are the most potent inhibitors of the dopamine-specific responses of the olfactory tubercle (OT); like atypical neuroleptics (2), they are far less effective when injected in the nucleus accumbens (ACC). We suggest that 5-HT2, D2 and/or D1 antagonism within the olfactory tubercle is necessary, but not sufficient for the atypical profile of neuroleptics.
这项研究表明,5-羟色胺2拮抗剂酮色林和利坦色林在使用经典抗精神病药物的基础上,可减轻精神分裂症的阴性症状以及锥体外系副作用,它们是嗅结节(OT)多巴胺特异性反应的最有效抑制剂;与非典型抗精神病药物一样,注射到伏隔核(ACC)时效果要差得多。我们认为,嗅结节内的5-羟色胺2、多巴胺2和/或多巴胺1拮抗作用是必要的,但对于非典型抗精神病药物的特性来说并不充分。